Diyalize Girmeyen Kronik Böbrek Hastalarında Miyojenik Temporomandibular Hastalıkların Depresyon Ve Sağlıkla İlgili Yaşam Kalitesi İle İlişkisi

Öz

Giriş/Amaç:Bu çalışmada diyalize girmeyen kronik böbrek hastalarında(NDCKD) miyojenik temporomandibular hastalıklar(mTMH) ile depresyon ve yaşam kalitesi arasındaki ilişkinin araştırılması amaçlanmıştır. Gereç ve Yöntemler:Bu çalışma 214 diyalize girmeyen kronik böbrek hastasını içermekteydi. Miyojenik temporomandibular hastalık(mTMH) tanısı Fonseca Anamnestic Index'e (FAI) göre konuldu. Sağlıkla ilişkili yaşam kalitesi (HRQOL) kısa form-36 (SF-36) kullanılarak belirlendi. Depresyon, Beck Depresyon Envanteri (BDI) kullanılarak değerlendirildi. Bulgular:İkiyüz ondört hastanın % 40.6'sına miyojenik TMH tanısı konuldu. Evre 3,4 ve 5 NDCKD hastalarında mTMH prevalansı sırasıyla % 33.6, % 46.8 ve % 57.1 idi. Hastaların % 32,2'si depresyon tanısı aldı. NDCKD evre 3,4 ve 5'te depresyon prevalansı sırasıyla % 27.8, % 32.8 ve % 50 idi. Depresyon mTMH olan hastaların % 42.5'inde ve TMH 'si olmayanların % 25.1'inde saptandı (p=0.004). mTMH şiddeti, BDI skoru ve C-reaktif protein ile pozitif olarak ve SF-36'nın albümin, Fiziksel Bileşen Özet Skoru ve Mental Bileşen Özet skorları ile negatif olarak ilişkiliydi. SF-36 skoru, FAI ve BDI skorları ile istatistiksel olarak anlamlı negatif bir korelasyon gösterdi (p <0.05). Sonuç:Miyojenik TMH, diyalize girmeyen kronik böbrek hastaları arasında çok yaygındır ve depresyon ve sağlıkla ilgili yaşam kalitesi ile ilişkilidir.

Anahtar Kelimeler

• Kronik böbrek hastalığı
• Temporomandibular hastalıklar
• Depresyon
• Yaşam kalitesi

The Relationship Of Myogenic Temporomandibular Disorders With Depression And Health-Related Quality Of Life In Non-Dialysis Chronic Kidney Disease

Abstract

Objective:In this study it was aimed to investigate the relationship between myogenic temporomandibular disorders (mTMD) and depression and quality of life in non-dialysis chronic kidney disease (NDCKD). Methods:This study included 214 with NDCKD patients. The diagnosis of mTMD was based on the Fonseca Anamnestic Index (FAI). Health-related quality of life (HRQOL) was determined using the Short Form-36 (SF-36). Depression was assessed using the Beck Depression Inventory (BDI). Results:40.6% of 214 patients were diagnosed with mTMD. mTMD prevalence in stage-3, -4, and -5 NDCKD patients were 33.6%, 46.8%, and 57.1% respectively. 32.2% of the patients were diagnosed with depression. The prevalence of depression in NDCKD stage-3, -4 and 5 was 27.8%, 32.8% and 50%, respectively. Depression was detected in 42.5% of the patients presenting with mTMD and 25.1% with no TMD (p=0.004). mTMD severity was positively associated with the BDI score and C-reactive protein, and negatively with albumin, the Physical Component Summary Score, and Mental Component Summary scores of SF-36. SF-36 score showed a statistically significant negative correlation with FAI and BDI scores (p <0.05). Conclusion:Myogenic TMD is very common among patients with NDCKD patients and is related to depression and HRQOL.

Keywords

• Chronic kidney disease
• Temporomandibular disorders
• Depression
• Quality of life

References

1. 1. Adern B, Stenvinkel C, Sahlqvist L, Tegelberg A. Prevalence of temporomandibular dysfunction and pain in adult general practice patients. Acta Odontol Scandin. 2014; 72: 585-590.
2. 2. Borahan MO, Mayil M, Pekiner FN. Using cone beam computed tomography to examine the prevalence of condylar bony changes in a Turkish subpopulation. Niger J Clin Pract. 2016;19(2):259-266.
3. 3. Soydan SS, Deniz K, Uckan S, Unal AD, Tutuncu NB. Is the incidence of temporomandibular disorder increased in polycystic ovary syndrome? Br J Oral Maxillofac Surg 2014;52(9):822-826.
4. 4. Selaimen CM, Jeronymo JC, Brilhante DP, Grossi ML. Sleep and depression as risk indicators for temporomandibular disorders in a cross-cultural perspective: a case-control study. Int J Prosthodont. 2006;19(2):154-161.
5. 5. De La Torre Canales G, Câmara-Souza MB, Muñoz Lora VRM, Guarda-Nardini L, Conti PCR, Rodrigues Garcia RM, Del Bel Cury AA, Manfredini D. Prevalence of psychosocial impairment in temporomandibular disorder patients: A systematic review. J Oral Rehabil. 2018;45(11):881-889. doi: 10.1111/joor.12685. Epub 2018 Jul 17.
6. 6. Natu VP, Yap AU, Su MH, Irfan Ali NM, Ansari A. Temporomandibular disorder symptoms and their association with quality of life, emotional states and sleep quality in South-East Asian youths. J Oral Rehabil. 2018;45(10):756-763.
7. 7. Katon WJ. Epidemiology and treatment of depression in patients with chronic medical illness. Dialog Clin Neurosci 2011;13: 7–23.
8. 8. Ahrens T, Deuschle M, Krumm B, van der Pompe G, den Boer JA, Lederbogen F. Pituitary-adrenal and sympathetic nervous system responses to stress in women remitted from recurrent major depression. Psychosom Med. 2008;70(4):461-467.

9. 9. Palmer SC, Vecchio M, Craig JC, Tonelli M, Johnson DW, Nicolucci A, Pellegrini F, Saglimbene V, Logroscino G, Hedayati SS, Strippoli GF. Association between depression and death in people with CKD: a meta-analysis of cohort studies. Am J Kidney Dis. 2013;62(3):493-505. doi: 10.1053/j.ajkd.2013.02.369.
10. 10. Cunha FL, Tagliaferro EP, Pereira AC, Meneghim MC, Hebling E. Oral health of a Brazilian population on renal dialysis. Spec Care Dentist. 2007;27(6):227-231.
11. 11. Bots CP, Poorterman JH, Brand HS, Kalsbeek H, van Amerongen BM, Veerman EC, Nieuw Amerongen AV. The oral health status of dentate patients with chronic renal failure undergoing dialysis therapy. Oral Dis. 2006 Mar;12(2):176-80. doi: 10.1111/j.1601-0825.2005.01183.x.
12. 12. Takahashi T, Kondoh T, Fukuda M, Yamazaki Y, Toyosaki T, Suzuki R. Proinflammatory cytokines detectable in synovial fluids from patients with temporomandibular disorders. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998;85(2):135-141.
13. 13. Suvinen TI, Reade PC. Temporomandibular disorders: a critical review of the nature of pain and its assessment. J Orofac Pain. 1995;9(4):317-339.
14. 14. Kostrzewa-Janicka J, Jurkowski P, Nedzi-Gora M, Mierzwinska-Nastalska E. “Inflammatory markers in temporomandibular joint disorders. Cent Eur J Immunol. 2012; 37(3):290-293.
15. 15. Souza VA, Oliveira D, Barbosa SR, Corrêa JODA, Colugnati FAB, Mansur HN, Fernandes NMDS, Bastos MG. Sarcopenia in patients with chronic kidney disease not yet on dialysis: Analysis of the prevalence and associated factors. PLoS One. 2017; 27;12(4):e0176230. doi: 10.1371/journal.pone.0176230.
16. 16. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009 May 5;150(9):604-12. doi: 10.7326/0003-4819-150-9-200905050-00006.
17. 17. Fonseca DM, Bonfante G, Valle AL, De Freitas SFT. [Diagnóstico pela anamnese da disfunção craniomandibular] Rev Gaucha Odontol. 1994;4(1):23–32.
18. 18. Bevilaqua-Grossi D, Chaves TC, de Oliveira AS, Monteiro-Pedro V. Anamnestic index severity and signs and symptoms of TMD. Cranio. 2006;24(2):112-118.
19. 19. Hedayati SS, Bosworth HB, Kuchibhatla M, Kimmel PL, Szczech LA. The predictive value of self-report scales compared with physician diagnosis of depression in hemodialysis patients. Kidney Int 2006; 69:1662–1668.
20. 20. Hedayati SS, Finkelstein FO. Epidemiology, diagnosis, and management of depression in patients with CKD. Am J Kidney Dis 2009; 54: 741–752.
21. 21. Afsar B, Elsurer R, Yilmaz MI, Eyileten T, Yenicesu M. Irritable bowel syndrome in haemodialysis: Prevalence, link with quality of life and depression. Nephrology (Carlton). 2010;15(2):197-202.
22. 22. Han Y, Song X, Liu Y, Zhang W, Li J, Tu Y, Chang W. The effects of depression and age on sleep disturbances in patients with non-dialysis stage 3-5 chronic kidney disease: a single-center study. Int Urol Nephrol. 2020;52(4):739-748. doi: 10.1007/s11255-020-02416-y. Epub 2020 Mar 2.
23. 23. Ware JE, Jr, Sherbourne CD. The MOS 36-Item short-form health survey (SF-36) I: Conceptual frame work and item selection. Med Care 1992;30:473-483.
24. 24. Ware JE, Jr. SF-36 health survey update. Spine. 2000;25(24):3130-3139.
25. 25. Sung SA, Hyun YY, Lee KB, Park HC, Chung W, Kim YH, Kim YS, Park SK, Oh KH, Ahn C; KNOW-CKD Study Investigators. Sleep Duration and Health-Related Quality of Life in Predialysis CKD. Clin J Am Soc Nephrol. 2018;7;13(6):858-865. doi: 10.2215/CJN.11351017. Epub 2018 May 3.
26. 26. Brown SA, Tyrer F, Clarke AL, Lloyd-Davies LH, Niyi-Odumosu FA, Nah RGQ, Stein AG, Tarrant C, Smith AC. Kidney symptom questionnaire: Development, content validation and relationship with quality of life. J Ren Care. 2018;24. doi: 10.1111/jorc.12247.
27. 27. Berni KC, Dibai-Filho AV, Rodrigues-Bigaton D. Accuracy of the Fonseca anamnestic index in the identification of myogenous temporomandibular disorder in female community cases. J Bodyw Mov Ther. 2015;19(3):404-409.
28. 28. Al-Jabi SW, Sous A, Jorf F, Taqatqa M, Allan M, Sawalha L, Lubadeh E, Zyoud SH, Sweileh WM. Depression in patients treated with haemodialysis: a cross-sectional study. Lancet. 2018;21;391 Suppl 2:S41. doi: 10.1016/S0140-6736(18)30407-0. Epub 2018 Feb 21.
29. 29. Nilsson IM, List T, Drangsholt M. Prevalence of temporomandibular pain and subsequent dental treatment in Swedish adolescents. J Orofac Pain 2005;19:144–50.
30. 30. Cui C, Zheng L, Fan Y, Zhang J, Xu R, Xie J, Zhou X. Parathyroid hormone ameliorates temporomandibular joint osteoarthritic-like changes related to age. Cell Prolif. 2020;53(4):e12755. doi: 10.1111/cpr.12755. Epub 2020 Mar 10.
31. 31. Teles F, Amorim de Albuquerque AL, Freitas Guedes Lins IK, Carvalho Medrado P, Falcão Pedrosa Costa A. Quality of life and depression in haemodialysis patients. Send to Psychol Health Med. 2018;23(9):1069-1078.
32. 32. Shen M, Luo Y, Niu Y, et al. 1,25(OH)2D deficiency induces temporomandibular joint osteoarthritis via secretion of senescence-associated inflammatory cytokines. Bone. 2013;55(2):400-409.
33. 33. Jagur O, Kull M, Leibur E, Kallikorm R, Loorits D, Lember M, Voog-Oras U. Relationship between radiographic changes in the temporomandibular joint and bone mineral density: a population based study. Stomatologija. 2011;13(2):42-8.
34. 34. Haketa T, Kino K, Sugisaki M, Amemori Y, Ishikawa T, Shibuya T, Sato F, Yoshida N. Difficulty of food intake in patients with temporomandibular disorders. Int J Prosthodont. 2006;19(3):266-70.
35. 35. Romanos GE, Javed F, Romanos EB, Williams RC. Oro-facial manifestations in patients with eating disorders. Appetite. 2012;59(2):499-504.
36. 36. Nishioka M, Ioi H, Matsumoto R, Goto TK, Nakata S, Nakasima A, Counts AL, Davidovitch Z. TMJ osteoarthritis/osteoarthrosis and immune system factors in a Japanese sample. Angle Orthod. 2008;78(5):793-8. doi: 10.2319/091407-438.
37. 37. Jordani PC, Campi LB, Circeli GZ, Visscher CM, Bigal ME, Gonçalves DA. Obesity as a risk factor for temporomandibular disorders. J Oral Rehabil. 2017;44(1):1-8.
38. 38. Altman DG. Practical statistics for medical research. 1. London, UK: Chapman & Hall; 1991.